Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Parathyroid hormone (PTH) replacement refers to the therapeutic use of recombinant or synthetic forms of PTH to treat conditions where endogenous PTH is deficient, most notably hypoparathyroidism. It aims to restore more physiological regulation of serum calcium, reduce complications associated with standard therapy, and improve quality of life.
Mimics endogenous PTH action at target tissues by binding to and activating the parathyroid hormone/parathyroid hormone-related protein receptor type 1 (PTHR1)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parathyroid Hormone Replacement (None).